MARC details
| 000 -LEADER |
|---|
| fixed length control field |
04399aam a22003614i 4500 |
| 001 - CONTROL NUMBER |
|---|
| control field |
13123985 |
| 003 - CONTROL NUMBER IDENTIFIER |
|---|
| control field |
EG-NcFUE |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20200922114651.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
030314s2003 enka b 001 0 eng |
| 010 ## - LIBRARY OF CONGRESS CONTROL NUMBER |
|---|
| LC control number |
2003045085 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
0470843268 (cloth : alk. paper) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
0470843276 (pbk. : alk. paper) |
| 040 ## - CATALOGING SOURCE |
|---|
| Original cataloging agency |
DLC |
| Transcribing agency |
DLC |
| Modifying agency |
DLC |
| 042 ## - AUTHENTICATION CODE |
|---|
| Authentication code |
pcc |
| 050 00 - LIBRARY OF CONGRESS CALL NUMBER |
|---|
| Classification number |
RS380 |
| Item number |
.W34 2003 |
| 082 00 - DEWEY DECIMAL CLASSIFICATION NUMBER |
|---|
| Classification number |
615.19 |
| Edition number |
21 |
| Item number |
W.G.B |
| 100 1# - MAIN ENTRY--PERSONAL NAME |
|---|
| Personal name |
Walsh, Gary, |
| Titles and other words associated with a name |
Dr., |
| Relator term |
author. |
| 245 10 - TITLE STATEMENT |
|---|
| Title |
Biopharmaceuticals : |
| Remainder of title |
biochemistry and biotechnology / |
| Statement of responsibility, etc |
Gary Walsh. |
| 250 ## - EDITION STATEMENT |
|---|
| Edition statement |
Second edition. |
| 264 #1 - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) |
|---|
| Place of publication, distribution, etc |
Chichester, West Sussex, England ; |
| -- |
Hoboken, NJ : |
| Name of publisher, distributor, etc |
J. Wiley, |
| Date of publication, distribution, etc |
[2003] |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
xviii, 551 pages : |
| Other physical details |
illustrations ; |
| Dimensions |
24 cm |
| 336 ## - CONTENT TYPE |
|---|
| Source |
rdacontent |
| Content type term |
text |
| 337 ## - MEDIA TYPE |
|---|
| Source |
rdamedia |
| Media type term |
unmediated |
| 338 ## - CARRIER TYPE |
|---|
| Source |
rdacarrier |
| Carrier type term |
volume |
| 500 ## - GENERAL NOTE |
|---|
| General note |
pharmacy bookfair2016 |
| 504 ## - BIBLIOGRAPHY, ETC. NOTE |
|---|
| Bibliography, etc |
Includes bibliographical references and index. |
| 505 0# - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
Contents -- Preface -- Chapter 1 Pharmaceuticals, biologics and biopharmaceuticals -- Introduction to pharmaceutical products -- Biopharmaceuticals and pharmaceutical biotechnology -- History of the pharmaceutical industry -- The age of biopharmaceuticals -- Biopharmaceuticals: current status and future prospects -- Traditional pharmaceuticals of biological origin -- Pharmaceuticals of animal origin -- The sex hormones -- The androgens -- Oestrogens -- Progesterone and progestogens -- Corticosteroids -- Catecholamines -- Prostaglandins Pharmaceutical substances of plant origin Alkaloids -- Atropine and scopalamine -- Morphine and cocaine -- Additional plant alkaloids -- Ergot alkaloids -- Flavonoids, xanthines and terpenoids -- Cardiac glycosides and coumarins -- Aspirin -- Pharmaceutical substances of microbial origin -- The macrolides and ansamycins -- Peptide and other antibiotics -- Conclusion -- Further reading -- Chapter 2 The drug development process -- Drug discovery -- The impact of genomics and related technologies upon drug discovery -- Gene chips -- Proteomics -- Structural genomics -- Pharmacogenetics -- Plants as a source of drugs -- Microbial drugs Rational drug design Combinatorial approaches to drug discovery -- Initial product characterization -- Patenting -- What is a patent and what is patentable? -- Patent types -- The patent application -- Patenting in biotechnology -- Delivery of biopharmaceuticals -- Oral delivery systems -- Pulmonary delivery -- Nasal, transmucosal and transdermal delivery systems -- Pre-clinical trials -- Pharmacokinetics and pharmacodynamics -- Toxicity studies -- Reproductive toxicity and teratogenicity -- Mutagenicity, carcinogenicity and other tests -- Clinical trials -- Clinical trial design -- Trial size and study population Randomized control studies Additional trial designs -- The role and remit of regulatory authorities -- The Food and Drug Administration -- The investigational new drug application -- The new drug application -- European regulations -- National regulatory authorities -- The EMEA and the new EU drug approval systems -- The centralized procedure -- Mutual recognition -- Drug registration in Japan -- World harmonization of drug approvals -- Conclusion -- Further reading -- Chapter 3 The drug manufacturing process -- International pharmacopoeia -- Martindale, the Extra Pharmacopoeia -- Guides to good manufacturing practice The manufacturing facilityClean rooms -- Cleaning, decontamination and sanitation (CDS) -- CDS of the general manufacturing area -- CDS of process equipment -- Water for biopharmaceutical processing -- Generation of purified water and water for injections (WFI) -- Distribution system for WFI -- Documentation -- Specifications -- Manufacturing formulae, processing and packaging instructions -- Records -- Generation of manufacturing records -- Sources of biopharmaceuticals -- E. coli as a source of recombinant, therapeutic proteins -- Expression of recombinant proteins in animal cell culture systems |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Pharmaceutical biotechnology. |
| 856 ## - ELECTRONIC LOCATION AND ACCESS |
|---|
| Materials specified |
Abstract |
| Uniform Resource Identifier |
<a href="http://repository.fue.edu.eg/xmlui/handle/123456789/1803">http://repository.fue.edu.eg/xmlui/handle/123456789/1803</a> |
| 906 ## - LOCAL DATA ELEMENT F, LDF (RLIN) |
|---|
| a |
7 |
| b |
cbc |
| c |
orignew |
| d |
1 |
| e |
ocip |
| f |
20 |
| g |
y-gencatlg |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Source of classification or shelving scheme |
Dewey Decimal Classification |
| Koha item type |
Books |